Sangamo Therapeutics, Inc. is Founded in 1995, company Headquarters is located in Brisbane, California, USA. It is an American Pioneering Genetic Cures biotechnology company. It applies cell and gene therapy to fight hemophilia and other hereditary diseases. Sangamo also applies technology to treat hemophilia B and lysosomal storage diseases including mucopolysaccharidosis type and mucopolysaccharidosis type II. Sangamo practices Bioverativ in hemoglobinopathies in beta-thalassemia and for sickle cell disease. It is also working on zinc finger gene-editing technology. Sangamo Therapeutics, Inc. offers a complete suite of benefits to promote the health and financial security of their employees by providing them Insurance, Flexible Spending Accounts, and Health Care facilities.
LENSA generates certain information provided on this website by compiling and analyzing publicly available data and data from employees/former employees. All company names are the registered trademarks of their original owners. The use of any trade name or trademark does not imply any association with the third-party company. None of the information provided is endorsed in any way by any of the companies mentioned. We do not guarantee the accuracy, currency, or suitability of this information (including regarding demographics or salary estimate) and you are responsible for how you use it. ALL INFORMATION IS PROVIDED “AS IS” AND “WITH ALL FAULTS”. We are not responsible for nor endorse third party content on our website. If you notice any inaccurate information or information you think is proprietary you can email us at [email protected]. See our Terms and Conditions and Community Guidelines for more information.
How do I match this company?
